22/08/2026
Anaphylactic vs Neurogenic Shock: Two Distributive Shocks, Two Very Different Mechanisms
Both can produce hypotension and tissue hypoperfusion, but the pathophysiology—and the first response—are fundamentally different.
🔴 ANAPHYLACTIC SHOCK
An IgE-mediated hypersensitivity reaction triggers mast-cell mediator release, causing vasodilation, increased capillary permeability, and bronchospasm.
Think:
Allergen → mediator release → vasodilation + capillary leak → airway compromise → shock
Key clues include urticaria/angioedema, wheeze, bronchospasm, warm flushed skin, and usually tachycardia.
🚨 First-line treatment: IM epinephrine.
Do not wait for hypotension to become profound when anaphylaxis is suspected.
🔵 NEUROGENIC SHOCK
Loss of sympathetic vascular tone—typically after significant spinal cord injury or high neuraxial blockade—causes vasodilation, reduced systemic vascular resistance, hypotension, and classically bradycardia.
Think:
Loss of sympathetic tone → vasodilation → hypotension + bradycardia → impaired perfusion
Key clues include hypotension with relative bradycardia, warm/dry skin, and the absence of typical allergic skin or airway findings.
🚨 Management centers on hemodynamic support, spinal stabilization when indicated, and treatment of the underlying neurologic cause.
The high-yield distinction
Anaphylaxis = mediator-driven vasodilation + capillary leak + airway involvement → EPINEPHRINE
Neurogenic shock = loss of sympathetic tone + vasodilation + BRADYCARDIA → hemodynamic support + spinal management
Recognizing the mechanism is what turns a list of symptoms into the correct emergency response.
Educational content for healthcare professionals. Management should be individualized to the clinical presentation and current protocols.